Highlights and Quick Summary
- Consolidated Net Income/Loss for the quarter ending September 30, 2022 was $-23.1 Million (a -17.28% decrease compared to previous quarter)
- Year-over-year quarterly Consolidated Net Income/Loss decreased by -21.88%
- Annual Consolidated Net Income/Loss for 2021 was $-109 Million (a 26.63% increase from previous year)
- Annual Consolidated Net Income/Loss for 2020 was $-86.3 Million (a 27.93% increase from previous year)
- Annual Consolidated Net Income/Loss for 2019 was $-67.5 Million (a 77.86% increase from previous year)
- Twelve month Consolidated Net Income/Loss ending September 30, 2022 was $-105 Million (a -3.92% decrease compared to previous quarter)
- Twelve month trailing Consolidated Net Income/Loss decreased by -3.66% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-105 Million | $-110 Million | $-108 Million | $-109 Million |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Consolidated Net Income/Loss of Atreca, Inc.
Most recent Consolidated Net Income/Lossof BCEL including historical data for past 10 years.Interactive Chart of Consolidated Net Income/Loss of Atreca, Inc.
Atreca, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-23.06 | $-27.88 | $-24.88 | – |
| 2021 | $-29.52 | $-27.36 | $-26.68 | $-25.78 | $-109.32 |
| 2020 | $-23.01 | $-22.93 | $-19.98 | $-20.42 | $-86.33 |
| 2019 | $-20.11 | $-15.87 | $-17.92 | $-13.58 | $-67.48 |
| 2018 | – | – | $-9.63 | $-8.67 | $-37.94 |
| 2017 | – | – | – | – | $-27.53 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology